Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-12

Clinical Trial Update: Machine Learning Assessment of Next-Day Migraine Likelihood

View source ↗

Summary

A Theranica-sponsored clinical trial evaluating a machine learning approach to predict the likelihood of a migraine on the following day has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Theranica | Conditions: Migraine | Status: COMPLETED